← Leaderboards
Amelia N Deitchman
University Of California, San Francisco
$1,849,448
Attributed
$3,714,838
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,714,838 · 3
By mechanism
RM1$2,331,737 · 1
K23$956,701 · 1
R21$426,400 · 1
Top collaborators
- Timothy Jensen Henrich1 shared
- Sulggi Angela Lee1 shared
- Zian H Tseng1 shared
- Henry F. Vanbrocklin1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Nisha Acharya$16,289,853
- Timothy Jensen Henrich$17,762,972
- Adam R. Abate$16,378,110
- Glenn-Milo Santos$8,436,377
- Stephen Starko Francis$2,607,031
Others in their field
Other Emerging Leaders on “Viral”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$160,855,334
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,911,178
- John Damon Chodera · Sloan-Kettering Inst Can Research$51,025,260
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- Thomas Denny · Duke University$37,546,967
Research focus
ViralPharmacodynamicsImmuneDrug KineticsSamplingAnti-Retroviral AgentsImmune ResponseParticipantPersonsViral ReboundNeutralizing AntibodyClinical TrialsImmune TargetingVaccinesDosePharmacologyInflammatoryFutureImmune FunctionPharmaceutical PreparationsAntiretroviral TherapyCellsInterruptionChronic
Grant awards (8)
In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART$2,331,737
RM1 · FY2025 · DA
Characterizing Antiviral Washout and Viral Rebound during Analytic Treatment Interruption Studies$205,000
R21 · FY2025 · AI · contact PI
Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives$152,101
K23 · FY2025 · AI · contact PI
Characterizing Antiviral Washout and Viral Rebound during Analytic Treatment Interruption Studies$221,400
R21 · FY2024 · AI · contact PI
Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives$201,150
K23 · FY2024 · AI · contact PI
Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives$201,150
K23 · FY2023 · AI · contact PI
Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives$201,150
K23 · FY2022 · AI · contact PI
Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives$201,150
K23 · FY2021 · AI · contact PI